WORLDRegeneron’s Pasatru Wins FDA Approval for FOPTabassum ChaudharyAugust 20, 2026August 20, 2026 August 20, 2026August 20, 2026 The FDA approved Regeneron’s Pasatru for FOP, an ultra-rare bone disorder, after Phase 3 trials showed strong drops in new bone growth. FOP causes muscle,...